These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model. Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432 [TBL] [Abstract][Full Text] [Related]
3. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model. Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081 [TBL] [Abstract][Full Text] [Related]
4. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts. Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147 [TBL] [Abstract][Full Text] [Related]
5. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish. Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829 [TBL] [Abstract][Full Text] [Related]
6. An orthotopic glioblastoma animal model suitable for high-throughput screenings. Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of GPR68 kills glioblastoma in zebrafish xenograft models. Neitzel LR; Fuller DT; Williams CH; Hong CC BMC Res Notes; 2024 Aug; 17(1):235. PubMed ID: 39180089 [TBL] [Abstract][Full Text] [Related]
8. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma. Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508 [TBL] [Abstract][Full Text] [Related]
9. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion. Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143 [TBL] [Abstract][Full Text] [Related]
10. Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain. Peglion F; Coumailleau F; Etienne-Manneville S J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969108 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
12. Hallmarks of tumor-associated microglia response to experimental U87 human glioblastoma xenograft. Dugandžija T; Drljača J; Bulajić D; Isaković A; Stilinović N; Sekulić S; Čapo I Tissue Cell; 2021 Oct; 72():101557. PubMed ID: 34051646 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence. Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949 [TBL] [Abstract][Full Text] [Related]
14. Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. Candolfi M; Curtin JF; Nichols WS; Muhammad AG; King GD; Pluhar GE; McNiel EA; Ohlfest JR; Freese AB; Moore PF; Lerner J; Lowenstein PR; Castro MG J Neurooncol; 2007 Nov; 85(2):133-48. PubMed ID: 17874037 [TBL] [Abstract][Full Text] [Related]
15. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth. Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044 [TBL] [Abstract][Full Text] [Related]
16. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534 [TBL] [Abstract][Full Text] [Related]
17. Evaluating cancer cell line and patient-derived xenograft recapitulation of tumor and non-diseased tissue gene expression profiles in silico. Williams AS; Wilk EJ; Fisher JL; Lasseigne BN Cancer Rep (Hoboken); 2023 Sep; 6(9):e1874. PubMed ID: 37533331 [TBL] [Abstract][Full Text] [Related]
18. ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma. Cam M; Charan M; Welker AM; Dravid P; Studebaker AW; Leonard JR; Pierson CR; Nakano I; Beattie CE; Hwang EI; Kambhampati M; Nazarian J; Finlay JL; Cam H Neuro Oncol; 2020 Mar; 22(3):345-356. PubMed ID: 31763674 [TBL] [Abstract][Full Text] [Related]
19. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors. Upton DH; Ziegler DS; Tsoli M Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797 [TBL] [Abstract][Full Text] [Related]
20. Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis. Morimoto T; Nakazawa T; Matsuda R; Maeoka R; Nishimura F; Nakamura M; Yamada S; Park YS; Tsujimura T; Nakagawa I Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]